Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
5563 | PRKAA2 | protein kinase AMP-activated catalytic subunit alpha 2 | |
5621 | PRNP | prion protein (Kanno blood group) | |
5743 | PTGS2 | prostaglandin-endoperoxide synthase 2 | |
5973 | RENBP | renin binding protein | |
6515 | SLC2A3 | solute carrier family 2 member 3 | |
6517 | SLC2A4 | solute carrier family 2 member 4 | |
7108 | TM7SF2 | transmembrane 7 superfamily member 2 | |
7351 | UCP2 | uncoupling protein 2 | |
7903 | ST8SIA4 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | |
8526 | DGKE | diacylglycerol kinase epsilon |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
16846 | Lep | leptin | |
19017 | Ppargc1a | peroxisome proliferative activated receptor, gamma, coactivator 1 alpha | |
22228 | Ucp2 | uncoupling protein 2 (mitochondrial, proton carrier) | |
67375 | Qprt | quinolinate phosphoribosyltransferase | |
105787 | Prkaa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit |
Gene ID | Gene Symbol | Description | Source |
---|---|---|---|
25591 | Parp1 | poly (ADP-ribose) polymerase 1 | |
25608 | Lep | leptin | |
54315 | Ucp2 | uncoupling protein 2 | |
65248 | Prkaa1 | protein kinase AMP-activated catalytic subunit alpha 1 | |
83516 | Ppargc1a | PPARG coactivator 1 alpha | |
293504 | Qprt | quinolinate phosphoribosyltransferase |
HPO ID | HPO Term |
---|---|
HP:0002375 | Hypokinesia |
HP:0002500 | Abnormal cerebral white matter morphology |
HP:0002540 | Inability to walk |
HP:0002591 | Polyphagia |
HP:0003107 | Abnormal circulating cholesterol concentration |
HP:0003324 | Generalized muscle weakness |
HP:0003487 | Babinski sign |
HP:0004305 | Involuntary movements |
HP:0004408 | Abnormality of the sense of smell |
HP:0007010 | Poor fine motor coordination |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024